Drug Shortage Report for CARBOPLATIN INJECTION BP

Last updated on 2017-11-14 History
Report ID 21747
Drug Identification Number 02126680
Brand name CARBOPLATIN INJECTION BP
Common or Proper name CARBOPLATIN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CARBOPLATIN
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1x60mL
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-10-26
Actual start date
Estimated end date 2017-12-15
Actual end date 2017-11-09
Shortage status Resolved
Updated date 2017-11-14
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-11-14 French Compare
v5 2017-11-14 French Compare
v4 2017-11-14 English Compare
v3 2017-10-27 English Compare
v2 2017-09-08 French Compare
v1 2017-09-08 English Compare